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560 Abstracts February 2014treatment was delayed by uncertainty regarding the source. In all three,
initial aneurysm dilatation was followed by shrinkage. The failed treatment
of a type I endoleak in a case of aortoiliac dissection resulted in the only
rupture in the entire series. Type II endoleaks were not treated.
Conclusions: Persistent aneurysm dilatation was a rare event after
endovascular repair using a multibranched endovascular stent graft, prob-
ably because most direct endoleaks (types I and III) were treated, whereas
untreated type II endoleaks appear to have had little effect on aneurysm size.
Outcomes of Lower Extremity Revascularization (LER) in Patients on
Dialysis
Justin Wallace, MD, Joseph Sidaoui, MD, Larry Fish, PhD, Luke
Marone, MD, Donald Baril, MD, Efthimios Avgerinos, MD, Michel
Makaroun, MD, Rabih A. Chaer, MD. University of Pittsburgh,
Pittsburgh, Pa
Objectives: Dialysis patients with peripheral vascular disease (PVD)
are at high risk for complications after surgical bypass, and it is not clear if
endovascular interventions have affected survival and limb salvage in this pa-
tient population. We sought to characterize the outcomes of endovascular
(endo) and open revascularization in dialysis patients treated for claudica-
tion or critical limb ischemia (CLI).
Methods: The United States Renal Data System (USRDS) was used
to review all patients undergoing lower extremity revascularization (LER)
in dialysis patients in the United States between 2005 and 2008. Diagnoses
and procedures were identiﬁed by International Classiﬁcation of Diseases-
9th Revision and Current Procedural Terminology codes, respectively. Pri-
mary outcomes were mortality and limb salvage. Bivariate associations were
tested using the c2 test, and predictors were identiﬁed using Cox regression
models.
Results: A total of 12,029 incident dialysis patients underwent LER
(24% endo, 76% open). CLI was the indication in 79.9% of endo LER,
and 72.8% of open LER. The major amputation rate #30 days for CLI pa-
tients was 15.1% (15.7% endo, 13.1% open; P ¼ .002) and for claudicant
patients was 5.2% (5.2% endo, 4.9% open; P ¼ .771). At 1 year, 32.0% of
CLI patients (33.0% endo, 29.1% open; P < .001) and 14.4% of claudicant
patients (14.0% endo, 16.4% open; P ¼ .254) had undergone a major ampu-
tation. The mortality rate at 30 days for CLI patients was 7.8% (7.2% endo,
9.8% open; P ¼ .001) and for claudicant patients was 5.2% (4.7% endo, 7.9%
open; P ¼ .018). At 1 year, the mortality rate was 38.4% for CLI patients
(37.6% endo, 40.9% open; P ¼ .005) and 25.7% for claudicant patients
(25.7% endo, 25.2% open; P ¼ .820). There were no signiﬁcant differences
between estimated survival for endo and open procedures at 1 year when
stratiﬁed by clinical indication. Estimated limb salvage differed signiﬁcantly
between open and endo LER only among CLI patients, with open LER
associated with improved limb salvage (P ¼ .001; Fig). Signiﬁcant pre-
dictors of post-LER mortality were older age (P < .001) and congestive
heart failure (P < .001).
Conclusions: Mortality and amputation rates after LER for dialysis
patients are signiﬁcant, particularly for patients with CLI. Although open
LER is associated with improved limb salvage compared with endo LER,
mortality is greater at 30 days and 1 year. Given the high overall mortality
rates, the presence of dialysis-dependence questions the indication for LER,
especially for claudication.
Fig. Amputation survival rates by indication and type of
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Objectives: Long-term results comparing percutaneous transluminal
angioplasty 6 stent (PTA/S) and surgical bypass grafting (BPG) for critical
limb ischemia (CLI) in patients who have had no prior intervention
have not been extensively reported. We detail our results with 3-year
follow-up.
Methods: We reviewed all lower extremity revascularization proce-
dures at our institution from January 2005 to December 2010, where
927 patients presented for CLI and underwent a ﬁrst-time intervention.
Outcomes included complications, restenosis, symptom recurrence, reinter-
ventions, minor and major amputations, and mortality. Predictors for
reintervention and amputation were identiﬁed using a Cox regression
model.
Results: Of the 927 patients, 519 underwent BPG and 408 under-
went PTA/S. BPG were above the knee in 58% (40% vein) and below
the knee in 42% (100% vein). Mean age was 70.5 years (BPG) vs 72.4 years
(PTA/S; P ¼ .03), with more males undergoing BPG (64% vs 52%; P <
.01). Mean length of stay was 10 days for BPG vs 7.4 days for PTA/S (P
¼ .02), with 3-year reintervention rates signiﬁcantly lower in patients under-
going BPG (42% vs 54%; P < .01). There were no differences in perioper-
ative mortality (3% vs 2%; not signiﬁcant). Wound infection was 11% in BPG
patients; however, BPG showed improved freedom from restenosis of 78%
vs 67% at 3 years (odds ratio [OR], 1.6; 95% conﬁdence interval [CI], 1.2-
2.1). A Cox regression model of all patients showed that a reintervention
#3 years was predicted by PTA/S (OR, 1.6; 95% CI, 1.1-2.3; Fig) and a
history of smoking (OR, 1.3; 95% CI, 1.0-1.6). Major amputations were
predicted by gangrenous indications (OR, 1.9; 95% CI, 1.1-3.5) and were
not predicted by procedure type.
Conclusions: BPG for the primary treatment of CLI showed
improved freedom from restenosis and signiﬁcantly fewer reinterventions
than PTA/S #3 years but was associated with increased length of stay
and wound infection. Perioperative mortality and 3-year amputation rates
were similar between procedure types.
Fig. Freedom from reintervention.
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Objectives: Acute lower extremity ischemia secondary to thrombo-
embolism is a common problem treated by vascular surgeons. Contem-
porary data regarding this problem are sparse. This report examines a
10-year single-center experience with acute lower extremity thrombo-
embolism and describes the surgical management and outcomes
observed.
